Cancer genes and cholangiocarcinoma

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 28 SUPPL. 1, Issue , 1997, Pages 80-84

  Petmitr, Songsak ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; ETHNIC GROUP; GENETICS; HUMAN; INTRAHEPATIC BILE DUCT; JAPAN; MUTATION; ONCOGENE RAS; PATHOLOGY; THAILAND; TUMOR SUPPRESSOR GENE;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; ETHNIC GROUPS; GENES, P53; GENES, RAS; HUMANS; JAPAN; MUTATION; THAILAND;

EID: 0031306414     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Barbicid M. Ras genes. Annu Rev Biochem 1979; 56: 779-827.
2. Bos JL. ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682-9.
3. Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE. Detection of K-ras mutations in stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 1994; 54: 3568-73.
4. Canman CE, Chen C-Y, Lee M-H, Kastan MB. DNA damage response: p53 induction, cell cycle pertur bations, and apoptosis. Cold Spring Harbor Sym Quant Biol 1994; 59: 277-86.
5. Cheng J, Haas M. Sensitivity of detection of heterozygous point mutations in p53 cDNA by direct PCR sequencing. PCR Method Applic 1992; 1: 199-201.
6. der Vries MV, Bogaard ME, van den Elst H, Van Boom JH, van der Eb AL, Bos JL. A dot blot screening procedure for mutated ras oncogenes using synthetic oligonucleotides. Gene 1986; 50: 313-20.
7. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer epidemiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-78.
8. Haubruck H, McCormic F. Ras p21: effects and regulation. Biochem Blophys Acta 1991; 1027: 215-29.
9. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
10. Hooper ML. The role of p53 and Rb-1 genes in cancer, development and apoptosis. J Cell Sci, 1994; 18: (Suppl): 13-7.
11. Kiba T, Tsuda H, Pairojkul C, Inoue S, Sugimura T, Hirohashi S. Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand. Mol Carcinogenesis 1993; 8: 312-8.
12. Lee JH, Yang HM, .Bak UB, Rim HJ. Promoting role of Clonorchis sinensis infection on induction of cholang iocarcinoma during two-step carcinogenesis. Korean J Parasitol 1994; 32: 13-8.
13. Levi S, Urbano-Ispizua A, Gill R et al. Marshall CJ. Multiple K-ras codon 12 mutations in cholangiocarcinoma demonstrated with a sensitive polymerase chain reaction techniques. Cancer Res 1991; 51: 3497-502.
14. Levine AJ. Tumor suppressor genes. Sci Am Sci Med 1995; 2: 28-37.
15. Marshell CJ. Tumor suppressor genes. Cell 1991; 64: 313-27.
16. McMahon G, Davis E, Wagon GN. Characterization of c-Ki-ras oncogene alleles by direct sequencing of enzymatic amplified DNA from carcinogen-induced tumors. Proc Natl Acad Sci USA 1987; 84: 4974-87.
17. Migasena P, Changbumrung S. The role of nitrosamines in the cause of primary carcinoma. J Med Assoc Thai 1974; 57: 175-8.
18. Sirisinha S Liver flukes and cancer in Southeast Asia. J Sci Soc Thai 1994; 20: 1-8.
19. Sithithaworn P, Haswell-Elkins MR, Mairiang P, et al. Parasite-associated morbidity: liver fluke infection and bile duct cancer in Northeast Thailand. Int J Parasitol 1994; 24: 833-43.
20. Smith ML, Chen I-T, Zhan Q, et al. Interaction of the p53 regulated protein Gadd45 with proliferating cell nuclear antigen. Science 1994; 266: 1376-80.
21. Soussi T, de Fromentel CC, May P. Structure aspects of the p53 protein in relation to gene evolution. Oncogene 1990; 5: 945-52.
22. Sozzi G, Miozzo M, Donghi R, et al. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res 1992; 52: 6079-82.
23. Suzuki Y, Sekiya T, Hayashi K. Allele-specific polymerase chain reaction : a method for amplified and sequence determination of single component among a mixture of sequence varients. Anal Biochem 1991; 192: 82-4.
24. Tada M, Yokosuka O, Omata M, Ohto M, Isono K. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing. Cancer 1990a; 66: 930-5.
25. Tada M, Omata M, Ohio M. Analysis of ras gene mutations in human hepatic malignant by polymerase chain reaction and direct sequencing. Cancer Res 1990b; 50: 1121-4.
26. Tada M, Omata M, Ohto M. High incidence of ras gene mutation in intrahepatic cholangiocarcinoma. Cancer 1992; 69: 1115-8.
27. Teneriello MG, Ebina M, Linnoila RI, et al. p53 and Ki-ras gene mutation in epithelial ovarian neoplasm. Cancer Res 1993; 53: 3103-8.
28. Thamavit W, Bhamarapravati N, Sahaphon S, Vajrasthira S, Angsubhakorn S. Effect of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini- infected Syrian golden hamsters. Cancer Res 1978; 38: 4634-9.
29. Thamavit W, Pairojkul C, Tiwaneech D, Shirai T, Ito N. Promotion of cholangiocarcinogenesis in the hamster liver bile duct ligation after dimethylnitrosamine initiation. Carcinogenesis 1993; 14: 2415-7.
30. Tsuda H, Satarug S, Bhudhisawasdi V, Kihana T, Sugimura T, Hirohashi S. Cholangiocarcinoma in Japanese and Thai patients : difference in ethiology and incidence of point mutation of the c-K-ras proto-oncogene. Mol Carcinogenesis 1992; 6: 266-9.
31. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alternation during colorectal tumor development. N Engl J Med 1988; 319: 525-32.
32. Weinberg RA. Molecular mechanisms of carcinogenesis. In : Leder P, et al eds. Introduction to molecular medicine New York: Scientific American, 1994; 277-305